Suvarna Garge (Editor)

Verily Life Sciences

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Formerly called
  
Google Life Sciences

Key people
  
Andrew Conrad (CEO)

Subsidiaries
  
Lift Labs

Parent organizations
  
Google, Alphabet Inc.

Type
  
Subsidiary

Owner
  
Google X (until 2015)

Founded
  
7 December 2015

Verily Life Sciences httpstctechcrunch2011fileswordpresscom2017

Industry
  
Health care Biotechnology

Verily (formerly Google Life Sciences) is Alphabet Inc.'s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, until 10 August 2015 when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc. This restructuring process was completed on October 2, 2015. On December 7, 2015, Google Life Sciences was renamed Verily.

Contents

Researchers

As of July 2014, members of the research team include Andrew Conrad, founder of LabCorp's National Genetics Institute; Vik Bajaj, an expert in nuclear magnetic resonance; Marija Pavlovic, who studies the effect of radiation on DNA; Alberto Vitari, a cancer biologist; Brian Otis, who worked on Google Venture's glucose-sensing contact lens; and Mark DePristo, who worked on the GATK at the Broad Institute. Dr. Thomas R. Insel announced on Sept. 15, 2015, that he was resigning as the director of the National Institute of Mental Health (NIMH) to join this division.

Acquisitions

On 9 September 2014, the division acquired Lift Labs, the makers of Liftware.

Projects

  • Contact lenses that allow people with diabetes to continually check their glucose levels using a non-intrusive method.
  • A spoon for people with tremors.
  • The Baseline Study, a project to collect genetic and molecular information from enough people to create a picture of what a healthy human should be.
  • A health-tracking wristband.
  • A disease-detecting nanoparticle platform. working with the wristband, a project called Tricorder
  • Advancements in surgical robotics, in partnership with Johnson & Johnson.
  • Development and commercialization of bioelectronic medicines, in partnership with GlaxoSmithKline
  • Development of miniaturized continuous glucose monitors (CGM) in partnership with Dexcom
  • References

    Verily Life Sciences Wikipedia


    Similar Topics